5-hydroxy-4-phenyl-2,3-dihydro-1,2-oxazol-3-one, 95.0%, 500mg

(R)-3-([1,1'-Biphenyl]-4-yl)-2-aminopropanoic acid, 95.0%, 5g

Neu5Ac alpha(2-3)Gal beta(1-4)Glc-beta-pNP>97.0%(HPLC)5mg

4-Phenylthiazole-2-thiol, 95.0%, 25g

3,5-Bis(trifluoromethyl)-benzeneethanamine, 97.0%, 5g

N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(1,1-dimethylethyl)benzamide, 98%, 10mg

4-Bromo-3-fluoro-N-methylbenzamide, 98%, 5g

{[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}amine hydrochloride hydrate, 95.0%, 1g

6-Chloro-7-methoxy-2-methyl-3-(4-(4-(trifluoromethoxy)phenoxy)phenyl)quinolin-4(1H)-one, 98.0%, 10mg

Acide N-Phénylanthranilique, min 97%, pa, 100 g, emballage plastique.

3-(3,4-DIMETHOXYPHENYL)-2,5-DIMETHYL-N-(2-MORPHOLINOETHYL)PYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE, 95%, 50mg

5-(CHLOROMETHYL)-1,3-DIMETHYL-1H-PYRAZOLE HCL, 95.0%, 100mg

(3-Ethyl-isoxazol-5-yl)-methanol, 95.0%, 1g